Click here to see all the TRIP Evidence Reviews.
Evidence-Based Reports
- National Knowledge Week - Biological Therapies for Psoriasis and Psoriatic Arthritis. NLH, 2006
- Adalimumab - Psoriasis. National Horizon Scanning Centre, 2006
- Infliximab for psoriasis. UKMI, 2005
Clinical Guidelines
- Psoriasis. British Association of Dermatologists, 2006
- Psoriasis. Finnish Medical Society Duodecim, 2005
- Biological Interventions for Psoriasis. British Association of Dermatologists, 2005
Systematic Reviews
- New Immunomodulating Drugs in Treating Moderate to Severe Psoriasis. Swedish Council on Technology Assessement, 2006
- Psoriasis - efalizumab and etanercept. NICE, 2006
- BG-12 for moderate to severe psoriasis - horizon scanning review. HTA, 2005
- Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis. NHS EED, 2005
- A cost comparison of treatments of moderate to severe psoriasis. NHS EED, 2005
Recent articles in core journals
- A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. NEJM, 2007
- Conventional systemic agents for psoriasis. A systematic review. J Rheumatol, 2006
- Biologic therapies for psoriasis. A systematic review. J Rheumatol, 2006
- Risk of myocardial infarction in patients with psoriasis. JAMA, 2006
- Chronic Plaque Psoriasis. American Family Physician, 2006
eTextbooks
Clinical queries
- Is alcohol a causative factor in psoriasis? NLH Q&A Service, 2006
- Is there any known link between the mirena IUS and psoriasis? NLH Q&A Service, 2006
- Is there a role for home use of UVB lamps in the treatment of psoriasis? NLH Q&A Service, 2006
Patient Information
